Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dick van Soolingen

Showing results (41-50 of 313) with videos related to

Pageof 32
Sort By:
Emerging Infectious Diseases|July 27, 2002
Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic reviewJudith R Glynn, Jennifer Whiteley, Pablo J Bifani, et al.
Diagnostic Microbiology and Infectious Disease|February 20, 2004
Two mycobacterium fortuitum strains isolated from pulmonary tuberculosis patients in Delhi harbour IS6110 homologueN Vijaya Bhanu, Dick van Soolingen, Jan D A van Embden, et al.
Journal of Clinical Microbiology|December 16, 2011
First worldwide proficiency study on variable-number tandem-repeat typing of Mycobacterium tuberculosis complex strainsJessica L de Beer, Kristin Kremer, Csaba Ködmön, et al.
Nature Clinical Practice. Rheumatology|November 28, 2008
Mycobacterial disease in patients with rheumatic diseaseJakko van Ingen, Martin J Boeree, P N Richard Dekhuijzen, et al.
International Journal of Antimicrobial Agents|December 17, 2009
In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The NetherlandsJakko van Ingen, Tridia van der Laan, Richard Dekhuijzen, et al.
Expert Review of Anti-Infective Therapy|October 16, 2013
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidenceJakko van Ingen, Beatriz E Ferro, Wouter Hoefsloot, et al.
International Journal of Antimicrobial Agents|May 14, 2013
Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significanceJakko van Ingen, Wouter Hoefsloot, Johan W Mouton, et al.
International Journal of Antimicrobial Agents|March 2, 2010
Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!Leonard Amaral, Martin J Boeree, Stephen H Gillespie, et al.
Plos One|August 23, 2011
A novel multiplex real-time PCR for the identification of mycobacteria associated with zoonotic tuberculosisKate Reddington, Justin O'Grady, Siobhan Dorai-Raj, et al.
Emerging Infectious Diseases|July 19, 2011
Multidrug-resistant Mycobacterium tuberculosis, Southwestern ColombiaBeatriz E Ferro, Luisa Maria Nieto, Juan C Rozo, et al.
Pageof 32

Showing results (41-50 of 313) with videos related to

Sort By:
Pageof 32
Emerging Infectious Diseases|July 27, 2002
Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic reviewJudith R Glynn, Jennifer Whiteley, Pablo J Bifani, et al.
Diagnostic Microbiology and Infectious Disease|February 20, 2004
Two mycobacterium fortuitum strains isolated from pulmonary tuberculosis patients in Delhi harbour IS6110 homologueN Vijaya Bhanu, Dick van Soolingen, Jan D A van Embden, et al.
Journal of Clinical Microbiology|December 16, 2011
First worldwide proficiency study on variable-number tandem-repeat typing of Mycobacterium tuberculosis complex strainsJessica L de Beer, Kristin Kremer, Csaba Ködmön, et al.
Nature Clinical Practice. Rheumatology|November 28, 2008
Mycobacterial disease in patients with rheumatic diseaseJakko van Ingen, Martin J Boeree, P N Richard Dekhuijzen, et al.
International Journal of Antimicrobial Agents|December 17, 2009
In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The NetherlandsJakko van Ingen, Tridia van der Laan, Richard Dekhuijzen, et al.
Expert Review of Anti-Infective Therapy|October 16, 2013
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidenceJakko van Ingen, Beatriz E Ferro, Wouter Hoefsloot, et al.
International Journal of Antimicrobial Agents|May 14, 2013
Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significanceJakko van Ingen, Wouter Hoefsloot, Johan W Mouton, et al.
International Journal of Antimicrobial Agents|March 2, 2010
Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!Leonard Amaral, Martin J Boeree, Stephen H Gillespie, et al.
Plos One|August 23, 2011
A novel multiplex real-time PCR for the identification of mycobacteria associated with zoonotic tuberculosisKate Reddington, Justin O'Grady, Siobhan Dorai-Raj, et al.
Emerging Infectious Diseases|July 19, 2011
Multidrug-resistant Mycobacterium tuberculosis, Southwestern ColombiaBeatriz E Ferro, Luisa Maria Nieto, Juan C Rozo, et al.
Pageof 32